World's Best Scientists 2026 revealed!
Michael Camilleri

Michael Camilleri

D-Index & Metrics

Best Scientists

D-Index
165
Citations
132214
World Ranking
1024
National Ranking
605

Medicine

D-Index
172
Citations
137997
World Ranking
487
National Ranking
288

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Michael Camilleri is affiliated with the Mayo Clinic in the United States. Their main field of study is Medicine, with a particular focus on Gastroenterology, Surgery, Physiology, Epidemiology, and Endocrinology, Diabetes and Metabolism as subfields. The scientist's research encompasses several main topics related to gastrointestinal health and metabolic processes.

The primary topics explored in their work include:

  • Gastrointestinal motility and disorders
  • Diet and metabolism studies
  • Gastroesophageal reflux and treatments
  • Helicobacter pylori-related gastroenterology studies
  • Microscopic Colitis
  • Diabetes Treatment and Management
  • Pharmacology and Obesity Treatment

Michael Camilleri has published extensively, contributing to multiple research venues. The most frequent venues for their publications are:

  • Gastroenterology
  • The American Journal of Gastroenterology
  • Neurogastroenterology & Motility
  • Alimentary Pharmacology & Therapeutics
  • Gut

Selected recent papers authored by Michael Camilleri include:

  • Diagnosis and Treatment of Irritable Bowel Syndrome, 2021, JAMA
  • ACG Clinical Guideline: Gastroparesis, 2022, The American Journal of Gastroenterology

Other highly cited recent papers in related areas, co-authored by various researchers, are:

  • Irritable bowel syndrome, 2020, The Lancet
  • Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome, 2020, Cell
  • International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function, 2020, Pharmacological Reviews

Michael Camilleri's frequent co-authors include:

  • Irene Busciglio
  • Saam Dilmaghani
  • Andrés Acosta
  • Joelle BouSaba
  • Duane D. Burton

Moreover, Michael Camilleri has contributed to book publications, including one published by Oxford University Press titled:

  • Mayo Clinic Illustrated Textbook of Neurogastroenterology, 2021

Among honors received, Michael Camilleri is recognized as a Member of the Association of American Physicians.

Best Publications

  • Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis

    Rohan Khera;Mohammad Hassan Murad;Apoorva K. Chandar;Parambir S. Dulai

  • Functional gastroduodenal disorders

    Jan Tack;Nicholas J. Talley;Michael Camilleri;Gerald Holtmann

  • AGA technical review on irritable bowel syndrome

    Douglas A. Drossman;Michael Camilleri;Emeran A. Mayer;William E. Whitehead

  • Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine.

    Thomas L. Abell;Michael Camilleri;Kevin Donohoe;William L. Hasler

  • Clinical Guideline: Management of Gastroparesis

    Michael Camilleri;Henry P. Parkman;Mehnaz A. Shafi;Thomas L. Abell

  • Irritable bowel syndrome: A technical review for practice guideline development

    DA Drossman;WE Whitehead;M Camilleri

  • Current concepts: Chronic constipation

    Anthony Lembo;Michael Camilleri

  • Intestinal barrier function in health and gastrointestinal disease

    M. Camilleri;K. Madsen;R. Spiller;B. G. Van Meerveld

  • Leaky gut: mechanisms, measurement and clinical implications in humans.

    Michael Camilleri

  • A placebo-controlled trial of prucalopride for severe chronic constipation.

    Michael Camilleri;René Kerstens;An Rykx;Lieve Vandeplassche

  • Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

    Michael Camilleri;Allison R Northcutt;Steven Kong;George E Dukes

  • Serotonin: a mediator of the brain-gut connection.

    Doe Young Kim;Michael Camilleri

  • A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome.

    H. J. Kim;M. Camilleri;S. Mckinzie;M. B. Lempke

  • Management of the irritable bowel syndrome

    Michael Camilleri

  • A Controlled Trial of Gluten-Free Diet in Patients With Irritable Bowel Syndrome-Diarrhea: Effects on Bowel Frequency and Intestinal Function

    Maria I. Vazquez–Roque;Michael Camilleri;Thomas Smyrk;Joseph A. Murray

  • Irritable bowel syndrome.

    Alexander C Ford;Alexander C Ford;Ami D Sperber;Maura Corsetti;Maura Corsetti;Michael Camilleri

  • Pyloric dysfunction in diabetics with recurrent nausea and vomiting.

    Fermin Mearin;Michael Camilleri;Juan R. Malagelada

  • Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome

    Charlene M. Prather;Michael Camilleri;Alan R. Zinsmeister;Sanna McKinzie

  • A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating.

    H. J. Kim;M. I. Vazquez Roque;Michael Camilleri;D. Stephens

  • Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome

    Michael Camilleri;Karen Lasch;Wen Zhou

Frequent Co-Authors

Duane Burton
Duane Burton Mayo Clinic
Adil E. Bharucha
Adil E. Bharucha Mayo Clinic
Nicholas J. Talley
Nicholas J. Talley University of Newcastle Australia
Phillip A. Low
Phillip A. Low Mayo Clinic
Henry P. Parkman
Henry P. Parkman Temple University
Robert A. Rizza
Robert A. Rizza Mayo Clinic
Jan Tack
Jan Tack KU Leuven

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare is becoming increasingly popular for those considering studying Medicine in the USA. Several online degree options allow for flexible study, quicker entry into the workforce, and diverse career opportunities.

For individuals holding a non-nursing bachelor's degree, direct entry np programs for non nurses online provide a fast-track route into advanced nursing roles. These programs are designed for career changers and can be completed online for maximum flexibility.

Those interested in foundational nursing can consider online adn programs for non nurses, which often have less stringent admission requirements, making nursing more accessible to a wider range of students.

Beyond clinical roles, medical billing and coding offers a viable entry into the healthcare field. Many schools provide financial aid for medical billing and coding programs, reducing upfront costs and improving access.

It's also worth asking, do all nursing schools require the teas? Some accredited programs do not, which can further lower barriers to entry for prospective students.

Best Scientists Citing Michael Camilleri

Trending Scientists